Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Feb 2026 for IDEAYA Biosciences, Inc., €15k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Douglas B. Snyder: trading record in brief
Douglas B. Snyder, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in GW Pharmaceuticals PLC and IDEAYA Biosciences, Inc. Between 5 May 2021 and 30 May 2025, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 2 February 2026, the filings show a share grant worth €15k in IDEAYA Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Douglas B. Snyder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,039 shares@ US$16.9065100.0% of flowCommon StockSEC:0001610717-26-000033:0
61,848 sharesOrdinary SharesSEC:0000899243-21-018666:0
2 of 2 declarations
